Fig. 7

Forest plot on progression free survival and overall survival in the validation cohort. Multivariable Cox regression model – Impact of tissue biomarkers on progression free survival and overall survival.#Adjusted for Stage, treatment (BRAFi+MEKi vs BRAFi); ## Adjusted for Stage, treatment (BRAFi+MEKi vs BRAFi), subsequent Immunotherapy (yes/no); i: intratumoral; p: peritumoral; CD8+/ CD163+ low: score 0,1+, high: score 2+,3 +